In this study, we demonstrated that lnc-MRPL39-2:1, was expressed mainly in the cytoplasm of the NPC cells, and bound directly bind to HuR to elevate the β-catenin expression level 13. The gene discussed is ELAVL1; the disease is nasopharyngeal carcinoma.